SCHEMBL1633776

SCHEMBL1633776

CC(=O)Nc1cccc(Nc2ncc3cccc(OC4CCN(C(C)C)CC4)c3n2)c1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 3/20 0.59
JAK1 P23458 3/20 0.59
TYK2 P29597 3/20 0.59
JAK3 P52333 3/20 0.59
SCN9A Q15858 6/20 0.52
MAP3K5 Q99683 2/20 0.51
TNIK Q9UKE5 1/20 0.49
EGFR P00533 2/20 0.43
ITK Q08881 1/20 0.43
MCHR1 Q99705 1/20 0.43
CSNK2A1 P68400 3/20 0.43
ABL1 P00519 2/20 0.42
PDGFRB P09619 1/20 0.42
SRC P12931 1/20 0.42
PDGFRA P16234 1/20 0.42
MAPK14 Q16539 1/20 0.42
KCNH2 Q12809 1/20 0.41
SCN5A Q14524 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632641 0.93 JAK2 (0.60) JAK2JAK1TYK2JAK3SCN9A
SCHEMBL1634270 0.90 TYK2 (0.55) JAK2JAK1TYK2JAK3SCN9A
SCHEMBL1633264 0.89 JAK2 (0.56) JAK2JAK1TYK2JAK3TNIK
SCHEMBL13498290 0.86 JAK2 (0.54) JAK2JAK1TYK2JAK3SCN9A
SCHEMBL1634187 0.86 JAK2 (0.57) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1632878 0.85 JAK2 (0.53) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1634396 0.85 JAK2 (0.53) JAK2JAK1TYK2JAK3SCN9A
SCHEMBL1632698 0.85 JAK2 (0.53) JAK2JAK1TYK2JAK3SCN9A
SCHEMBL1632967 0.85 JAK2 (0.53) JAK2JAK1TYK2JAK3SCN9A
SCHEMBL1632762 0.85 JAK2 (0.50) JAK2JAK1TYK2JAK3SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed